We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Egalet’s Morphine Tablet, But with a Narrower Abuse-Deterrent Label
FDA Approves Egalet’s Morphine Tablet, But with a Narrower Abuse-Deterrent Label
The FDA approved Egalet’s extended-release morphine tablet, Arymo ER, for daily, around-the-clock pain treatment, with specific labeling describing physical properties that can deter abuse through injection.